Clinical Trial Update: Efficacy and Safety Study of Xyotax to Treat Prostate Cancer [Phase 2]

View source ↗

Summary

This entry reports the completion of a Phase 2 trial evaluating Xyotax for prostate cancer, with results on efficacy and safety. The study was sponsored by The …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Xyotax (CT-2103)

Snippet

Sponsor: The Methodist Hospital Research Institute | Conditions: Prostatic Neoplasms | Phase 2 | Status: COMPLETED